Profile of Iron Overload in Nontransfusion Dependent Hb E Beta Thalassaemia Patients- Is It Different?

被引：0
作者：
Chowdhury, Prosanto Kumar [1 ,2 ]
Saha, Manash [2 ,3 ]
Basu, Anupam [4 ]
Chowdhury, Dhritidipa [5 ]
Jena, Rabindra Kumar [6 ]
机构：
[1] Peerless Hosp, Haemoglobinopathy & Thalassaemia, Kolkata, India
[2] BK Roy Res Ctr, Kolkata, India
[3] Peerless Hosp, Radiol, Kolkata, India
[4] Univ Burdwan, Dept Zool, Burdwan 713104, W Bengal, India
[5] Indian Railways, Kolkata, India
[6] SCB Med Coll, Clin Haematol, Cuttack, Orissa, India
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Deferasirox: A Review of Its Use for Chronic Iron Overload in Patients with Non-Transfusion-Dependent Thalassaemia
    Matt Shirley
    Greg L. Plosker
    [J]. Drugs, 2014, 74 : 1017 - 1027
  • [22] Deferasirox: A Review of Its Use for Chronic Iron Overload in Patients with Non-Transfusion-Dependent Thalassaemia
    Shirley, Matt
    Plosker, Greg L.
    [J]. DRUGS, 2014, 74 (09) : 1017 - 1027
  • [23] LIFETIME COST-UTILITY ANALYSES OF DEFERASIROX IN BETA THALASSAEMIA PATIENTS WITH CHRONIC IRON OVERLOAD: A UK PERSPECTIVE
    Karnon, J.
    Tolley, K.
    Chandiwana, D.
    Vieira, J.
    [J]. HAEMATOLOGICA, 2012, 97 : 387 - 387
  • [24] A 15-years follow-up of deferasirox in beta-thalassaemia major patients with iron overload
    Wei, Zhenbin
    Yang, Gaohui
    Huang, Yumei
    Peng, Peng
    Long, Liling
    Long, Yuan
    Huang, Xiaoping
    Zhou, Xuemei
    Lai, Yongrong
    Liu, Rongrong
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2020, 191 (03) : E81 - E83
  • [25] BUDGET IMPACT ANALYSIS OF DEFERASIROX FOR THE TREATMENT OF CHRONIC IRON OVERLOAD IN PATIENTS WITH BETA THALASSAEMIA IN VENETO REGION, ITALY
    Venturini, F.
    Adami, S.
    Alberti, C.
    Scroccaro, G.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A630 - A631
  • [26] Curcuminoids supplementation ameliorates iron overload, oxidative stress, hypercoagulability, and inflammation in non-transfusion-dependent β-thalassemia/Hb E patients
    Hatairaktham, Suneerat
    Masaratana, Patarabutr
    Hantaweepant, Chattree
    Srisawat, Chatchawan
    Sirivatanauksorn, Vorapan
    Siritanaratkul, Noppadol
    Panichkul, Narumol
    Kalpravidh, Ruchaneekorn W.
    [J]. ANNALS OF HEMATOLOGY, 2021, 100 (04) : 891 - 901
  • [27] Curcuminoids supplementation ameliorates iron overload, oxidative stress, hypercoagulability, and inflammation in non-transfusion-dependent β-thalassemia/Hb E patients
    Suneerat Hatairaktham
    Patarabutr Masaratana
    Chattree Hantaweepant
    Chatchawan Srisawat
    Vorapan Sirivatanauksorn
    Noppadol Siritanaratkul
    Narumol Panichkul
    Ruchaneekorn W. Kalpravidh
    [J]. Annals of Hematology, 2021, 100 : 891 - 901
  • [28] Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia
    Fisher, Sheila A.
    Brunskill, Susan J.
    Doree, Carolyn
    Gooding, Sarah
    Chowdhury, Onima
    Roberts, David J.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (08):
  • [29] Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia
    Roberts, D. J.
    Rees, D.
    Howard, J.
    Hyde, C.
    Alderson, P.
    Brunskill, S.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (04):
  • [30] Incidence of endocrine complications and clinical disease severity related to genotype analysis and iron overload in patients with beta-thalassaemia
    Jensen, CE
    Tuck, SM
    Old, J
    Morris, RW
    Yardumian, A
    DeSanctis, V
    Hoffbrand, AV
    Wonke, B
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 1997, 59 (02) : 76 - 81
12345